Patient-Derived Xenografts (PDX): Foundations & Workflow

October 1, 2025

Introduction Patient-Derived Xenografts (PDX) represent one of the most translationally relevant in vivo cancer models available to preclinical research. By directly implanting tumor fragments harvested from patients into immunodeficient mice,

Fundamentals of Xenograft Models in Preclinical Oncology

September 1, 2025

Introduction Xenograft models are indispensable tools in oncology research, providing a physiologically relevant in vivo platform to study tumor biology, evaluate therapeutic responses, and bridge the translational gap between preclinical

The XMD Project xenograft.org: A Centralized Resource for Preclinical In Vivo Cancer Models

August 1, 2025

Plymouth Meeting, PA – August 2025 – Cancer remains one of the greatest health burdens worldwide. Preclinical models are indispensable for developing therapies that can effectively translate from the laboratory